New Owner
Alexion Pharmaceuticals - Alexion Antibody Technologies
Alexion Pharmaceuticals acquires Alexion Antibody Technologies
Announced: September 25, 2000
Type: Acquisition
Disposition: Combined
Terms: Stock
Status: Complete
Amount: $ 41,000,000